BeiGene, Ltd. (BGNE) PT Lowered to $427 at Cowen

November 5, 2021 7:15 AM EDT Send to a Friend
Cowen analyst Yaron Werber lowered the price target on BeiGene, Ltd. (NASDAQ: BGNE) to $427.00 (from $441.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login